The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s anal fissure treatment market report forecasts the anal fissure treatment market size to grow to $1.80 Billion by 2027, with a CAGR (compound annual growth rate) of more than 8%.

Learn More On The Anal Fissure Treatment Market Report 2023 – https://www.thebusinessresearchcompany.com/report/anal-fissure-treatment-global-market-report

Anal Fissure Treatment Market Size Forecast
The global anal fissure treatment market is expected to grow from $1.20 billion in 2022 to $1.30 billion in 2023 at a compound annual growth rate (CAGR) of 9.0%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global anal fissure treatment market size is expected to grow to $1.80 billion in 2027 at a CAGR of 8.4%.

North America held the largest anal fissure treatment market share, and Asia-Pacific was the fastest-growing region in 2022.

Key Anal Fissure Treatment Market Driver ­– Increase In Elderly Population And Unhealthy Lifestyles
According to the World Health Organisation, a Switzerland-based specialised organisation responsible for international public health, the number of individuals aged 60 and over will outnumber children under the age of five in 2021, and this figure is anticipated to rise by 12% to 22% by 2050. Furthermore, the total number of preventable deaths related to poor dietary composition in 2021 was 9.3 million. As a result, the growing older population and unhealthy lifestyle are propelling the market for anal fissure therapy.

Request for A Sample Of The Global Anal Fissure Treatment Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9425&type=smp

Key Anal Fissure Treatment Market Trend – Increasing Constipation Rates
Constipation is characterised by stiff, dry, and difficult-to-pass stools as well as infrequent bowel movements. Painful constipation, as well as feeling bloated, unpleasant, and tired, are all possible symptoms. Anus lining injury, which most commonly happens in constipated patients, causes anal fissures that must be treated. As a result, the growing constipation population will drive market expansion. According to the National Library of Medicine, a US-based biomedical library, the global prevalence of constipation in 2021 was 12% to 19%, and approximately $7 billion was spent annually on testing for constipation. Furthermore, persistent constipation will impact roughly 63 million people in North America by 2020. As a result, the growing prevalence of constipation is propelling the anal fissure treatment market.

Anal Fissure Treatment Market Segment
1) By Type: Topical Nitroglycerin, Calcium Channel Blockers, Stool Softeners, Other Types
2) By Route of Administration: Topical, Oral
3) By Application: Clinics, Hospitals, Other Applications

Anal Fissure Treatment Market Major Players and Strategies
Major players in the anal fissure treatment market are SRS Life Sciences Inc., Healthy Life Pharma Private Limited, Eisai Co. Ltd., AstraZeneca Plc., Bayer AG, Novasep, Geri-care Pharmaceuticals Corp., Abbott Laboratories, GlaxoSmithKline Plc., Valeant Pharmaceuticals International Inc., Taro Pharmaceutical Industries Ltd., Cook Pharmica LLC, Pfizer Inc., Taj Pharmaceuticals Limited, Troikaa Pharmaceuticals Ltd., Purdue Pharma LP, and Allergan Inc.

AstraZeneca Plc., a UK-based pharmaceutical and biotechnology business focused on the discovery and commercialization of prescription medications, paid an unknown sum to purchase Alexion Pharmaceuticals Inc. in July 2021. The combined resources of AstraZeneca and Alexion are intended to increase AstraZeneca’s foray into medicines for rare diseases as well as drug discovery and development. Alexion Pharmaceuticals Inc. is a biopharmaceutical firm established in the United States that is focused on producing life-changing treatments.

The Anal Fissure Treatment Global Market Report 2023 covers regional data on anal fissure treatment market size, anal fissure treatment market trends and drivers, opportunities, strategies, and anal fissure treatment market competitor analysis. The countries covered in the anal fissure treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Anal fissure treatment is the mending of a minor tear in the thin, wet tissue that lines the anus utilising methods such as sitz baths or stool softeners. They are used to relax the sphincter muscles and enhance anal fissure healing.

View More Reports Related To The Anal Fissure Treatment Market –
Analgesics Global Market Report 2023
Polycystic Ovarian Syndrome Treatment Global Market Report 2023
Neutropenia Biologic Drug Treatment Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: